New Technology Provides Cutting Edge
Visualization, Ergonomic Positioning and Efficient Workflow
Bausch + Lomb, a leading global eye health company dedicated to
helping people see better to live better, and Heidelberg
Engineering, today announced the introduction of the SeeLuma™ Fully
Digital Surgical Visualization Platform, which provides ophthalmic
surgeons with a new level of visualization compared to optical,
hybrid and retrofitted microscopes. Developed to facilitate even
the most complex surgical procedures, SeeLuma will be introduced in
the United States and Western Europe this month with additional
countries to follow.
“As part of our broader mission, Bausch + Lomb aims to provide
ophthalmic surgeons around the world with innovative visualization
and intraoperative diagnostic technologies that enhance the
surgical experience to ultimately help deliver better patient
outcomes,” said Joe Gordon, president, Global Consumer, Surgical
and Vision Care, Bausch + Lomb. “The launch of SeeLuma is an
important milestone on this journey, as it will serve as one of the
key foundations for our future image-guided surgical
applications.”
SeeLuma features include a heads-up 3D monitor, multiple digital
display options and an intuitive interface that contribute to
excellent visualization, ergonomics, smooth workflow and an
immersive educational experience.
“SeeLuma addresses several challenges that many surgeons often
struggle with when using surgical microscopes that are currently
available,” said Siegfried Priglinger, professor, director and
chairman, University Eye Hospital of the
Ludwig-Maximilians-Universität, Munich, Germany. “Having access to
a platform that offers cutting edge visualization, efficient
workflow and ergonomics, and educational features has the potential
to really change the landscape and ultimately deliver tremendous
benefits for current and future generations of surgeons, as well as
their practices and patients.”
Premium Image Quality Enhances Visualization
SeeLuma offers high quality images as it relates to depth of
field, color reproduction and contrast and resolution, helping
surgeons tackle complicated surgical cases with confidence and
ease. The platform also facilitates 3D heads-up surgery using
next-generation 3D 55” and 31” 4K monitors, as well as unique
digital binoculars. In addition, embedded functions allow the user
to highlight and enhance anatomical landmarks to better distinguish
anatomical features.
Multiple Digital Display Options Support Ergonomic
Positioning
SeeLuma is the only microscope with multiple digital display
options that enables surgeons to operate ergonomically. The
C-shaped suspension arm enables surgeons to view the 55” or 31” 3D
4K monitor straight ahead of them. The digital binoculars are
mounted onto a separate suspension arm and allow surgeons to take
on an ergonomic posture and work with ease. Surgeons can maintain
proper head and neck posture even while working with a tilted
microscope camera head.
Intuitive Interface Facilitates Efficient Workflow
SeeLuma provides an intuitive interface with comprehensive
settings. Key system functionality can be controlled either by
nurses or directly by the operating surgeon using the on-screen
menu via the foot switch. System parameters, such as zoom and focus
speed, white balance, image inversion and foot control layouts, are
automatically adapted to surgical steps. In addition, the user
interface enables quick access to system functionality in an
intuitive way similar to that of personal computers or mobile
phones.
Interactive Platform Provides Immersive Educational
Experience
SeeLuma helps ensure that all stakeholders, including those in
and outside the operating room (OR), can participate in the
procedure in an immersive way. Surgeons can connect multiple
wireless displays simultaneously, allowing trainees and
stakeholders to follow and anticipate surgical steps as they occur
while in the OR and/or at a remote location. Surgeons can engage
the platform’s Assist Mode to send and receive real-time support
via touch screen interface and make annotations or notes on the
surgical image, which helps enable collaboration and learning
during live surgery events.
“For more than a decade, our Munich Surgical Imaging division,
has been collaborating with physicians to develop surgeon-centered
solutions that offer premium visualization and comfort to enhance
their surgical experience,” said Kfir Azoulay, head of Corporate
Strategy, Heidelberg Engineering, and managing director, Munich
Surgical Imaging (MSI). “Utilizing MSI’s digital microscopy and
image-guided applications expertise, coupled with Bausch + Lomb’s
long-standing leadership and innovation in ophthalmology, the new
SeeLuma platform will help address the increasing demand for
innovative digital microscopy solutions by providing surgeons with
outstanding imaging capabilities, ergonomics and digital tools to
tackle even the most complex ophthalmic surgical cases.”
About Heidelberg Engineering and Munich Surgical Imaging
Heidelberg Engineering is global leader in the field of
diagnostic imaging and healthcare IT solutions for ophthalmology.
Munich Surgical Imaging (MSI) – a wholly owned subsidiary of
Heidelberg Engineering – is a technological pioneer in the field of
digital microscopy and image-guided applications. MSI’s first
surgical platform in the field of ENT (Ear, Nose, and Throat) has
received accolades from surgeons on key parameters, such as
outstanding natural 3D image quality and blending of 3D image with
preoperative data. MSI’s state-of-the-art OCT technology is powered
by Heidelberg Engineering. For more information, visit
https://www.heidelbergengineering.com/ or
https://www.munichimaging.com/.
About Bausch + Lomb
Bausch + Lomb is dedicated to protecting and enhancing the gift
of sight for millions of people around the world – from the moment
of birth through every phase of life. Its comprehensive portfolio
of more than 400 products includes contact lenses, lens care
products, eye care products, ophthalmic pharmaceuticals,
over-the-counter products and ophthalmic surgical devices and
instruments. Founded in 1853, Bausch + Lomb has a significant
global research and development, manufacturing and commercial
footprint with approximately 13,000 employees and a presence in
nearly 100 countries. Bausch + Lomb is headquartered in Vaughan,
Ontario with corporate offices in Bridgewater, New Jersey. For more
information, visit www.bausch.com and connect with us on Twitter,
LinkedIn, Facebook and Instagram.
Forward-looking Statements
This news release may contain forward-looking statements, which
may generally be identified by the use of the words “anticipates,”
“hopes,” “expects,” “intends,” “plans,” “should,” “could,” “would,”
“may,” “believes,” “estimates,” “potential,” “target,” or
“continue” and variations or similar expressions. These statements
are based upon the current expectations and beliefs of management
and are subject to certain risks and uncertainties that could cause
actual results to differ materially from those described in the
forward-looking statements. These risks and uncertainties include,
but are not limited to, the risks and uncertainties discussed in
Bausch + Lomb’s filings with the U.S. Securities and Exchange
Commission and the Canadian Securities Administrators, which
factors are incorporated herein by reference. They also include,
but are not limited to, risks and uncertainties caused by or
relating to the evolving COVID-19 pandemic, and the fear of that
pandemic and its potential effects, the severity, duration and
future impact of which are highly uncertain and cannot be
predicted, and which may have a material adverse impact on Bausch +
Lomb, including but not limited to its project development
timelines, launches and costs (which may increase). Readers are
cautioned not to place undue reliance on any of these
forward-looking statements. These forward-looking statements speak
only as of the date hereof. Bausch + Lomb undertakes no obligation
to update any of these forward-looking statements to reflect events
or circumstances after the date of this news release or to reflect
actual outcomes, unless required by law.
®/TM are trademarks of Bausch & Lomb Incorporated or its
affiliates. Any other product/brand names and/or logos are
trademarks of the respective owners. © 2023 Bausch & Lomb
Incorporated or its affiliates. SRG.0021.USA.23
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230413005102/en/
Heidelberg Engineering: Kfir Azoulay
kfir.azoulay@heidelbergengineering.com
Bausch + Lomb Investor: Arthur Shannon/Allison Ryan
arthur.shannon@bausch.com;allison.ryan@bausch.com (877) 354-3705
(toll free); (908) 927-0735
Bausch + Lomb Media: Lainie Keller/Kristy Marks
lainie.keller@bausch.com;kristy.marks@bausch.com (908) 927-1198;
(908) 927-0683
Bausch plus Lomb (NYSE:BLCO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bausch plus Lomb (NYSE:BLCO)
Historical Stock Chart
From Jul 2023 to Jul 2024